BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27984651)

  • 1. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
    Mowery YM; Salama JK; Zafar SY; Moore HG; Willett CG; Czito BG; Hopkins MB; Palta M
    Cancer; 2017 Apr; 123(8):1434-1441. PubMed ID: 27984651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
    Guckenberger M; Saur G; Wehner D; Thalheimer A; Kim M; Germer CT; Flentje M
    Radiother Oncol; 2013 Aug; 108(2):326-30. PubMed ID: 24021342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
    Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY
    Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04).
    McLachlan SA; Fisher RJ; Zalcberg J; Solomon M; Burmeister B; Goldstein D; Leong T; Ackland SP; McKendrick J; McClure B; Mackay J; Ngan SY
    Eur J Cancer; 2016 Mar; 55():15-26. PubMed ID: 26771873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course radiation with consolidation chemotherapy does not increase operative morbidity compared to long-course chemoradiation: A retrospective study of the US rectal cancer consortium.
    Bauer PS; Gamboa AC; Otegbeye EE; Chapman WC; Rivard S; Regenbogen S; Mohammed M; Holder-Murray J; Wiseman JT; Ejaz A; Edwards-Hollingsworth K; Hawkins AT; Hunt SR; Balch G; Silviera ML
    J Surg Oncol; 2024 Feb; 129(2):254-263. PubMed ID: 37792637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial.
    Latkauskas T; Pauzas H; Kairevice L; Petrauskas A; Saladzinskas Z; Janciauskiene R; Gudaityte J; Lizdenis P; Svagzdys S; Tamelis A; Pavalkis D
    BMC Cancer; 2016 Dec; 16(1):927. PubMed ID: 27903247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
    Ngan SY; Burmeister B; Fisher RJ; Solomon M; Goldstein D; Joseph D; Ackland SP; Schache D; McClure B; McLachlan SA; McKendrick J; Leong T; Hartopeanu C; Zalcberg J; Mackay J
    J Clin Oncol; 2012 Nov; 30(31):3827-33. PubMed ID: 23008301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant short- or long-term radio(chemo)therapy for rectal cancer: how and who should be treated?
    Rödel C; Trojan J; Bechstein WO; Woeste G
    Dig Dis; 2012; 30 Suppl 2():102-8. PubMed ID: 23207941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Is Rectal Cancer Managed: a Survey Exploring Current Practice Patterns in Canada.
    Crawford A; Firtell J; Caycedo-Marulanda A
    J Gastrointest Cancer; 2019 Jun; 50(2):260-268. PubMed ID: 29388060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy.
    Wiltink LM; Nout RA; van der Voort van Zyp JR; Ceha HM; Fiocco M; Meershoek-Klein Kranenbarg E; Marinelli AW; van de Velde CJ; Marijnen CA
    Clin Colorectal Cancer; 2016 Sep; 15(3):e93-9. PubMed ID: 26968237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
    Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
    Guckenberger M; Saur G; Wehner D; Sweeney RA; Thalheimer A; Germer CT; Flentje M
    Strahlenther Onkol; 2012 Jul; 188(7):551-7. PubMed ID: 22638934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
    Wu B; Qiu HZ; Xiao Y; Lin GL; Niu BZ; Zhang FQ; Hu K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):124-7. PubMed ID: 18344077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer.
    Gollins S
    Colorectal Dis; 2010 Aug; 12 Suppl 2():2-24. PubMed ID: 20618363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
    Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reassessment of practice of Chinese surgeons since introduction of the watch and wait strategy after neoadjuvant therapy for rectal cancer].
    Zhao MH; Sun TT; Wang L; Huang YL; Xie XY; Lu Y; Zhao GH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):383-394. PubMed ID: 38644244
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.
    Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK
    Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
    Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxicity and surgical complications after preoperative (chemo)radiation therapy for rectal cancer in patients with inflammatory bowel disease.
    Bosch SL; van Rooijen SJ; Bökkerink GM; Braam HJ; Derikx LA; Poortmans P; Marijnen CA; Nagtegaal ID; de Wilt JH
    Radiother Oncol; 2017 Apr; 123(1):147-153. PubMed ID: 28291546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.